MONOCLONAL ANTIBODY 3F8
MONOCLONAL ANTIBODY 3F8 Uses, Dosage, Side Effects, Food Interaction and all others data.
MONOCLONAL ANTIBODY 3F8 is under investigation in clinical trial NCT00089258 (Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous Treatment).
| Trade Name | MONOCLONAL ANTIBODY 3F8 |
| Generic | Anti-GD2 monoclonal antibody 3F8 |
| Anti-GD2 monoclonal antibody 3F8 Other Names | MONOCLONAL ANTIBODY 3F8 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here MONOCLONAL ANTIBODY 3F8
